Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance  COVID-19 status Phase of research How it helps Latest publication
16-Glucuronide-estriol
Potential treatment - theoretical effect Experimental Antiviral Jul/31/2020
17-alpha-Hydroxywithanolide D
Potential treatment - theoretical effect Natural product Antiviral Mar/18/2021
18-Hydroxy-3-epi-alpha-yohimbine
Potential treatment - theoretical effect Natural product Antiviral Jul/17/2020
2'-C-Methylcytidine
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/29/2020
2,3-Dihydroamentoflavone
Potential treatment - theoretical effect Natural product Antiviral Jan/07/2021
2,5-dihydroxybenzoic acid
Potential treatment - theoretical effect Natural product Antiviral Dec/10/2020
2-((3,5-dichlorophenyl)amino)-5-hydroxyquinazolin-4 (3H)-one
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/02/2021
2-(2,3-Dihydro-1H-indol-1-ylcarbonyl)-N-(3-methylphenyl)quinazolin-4-amine
Potential treatment - theoretical effect Experimental Antiviral Dec/04/2020
2-(3-(3-Chloro-4-fluorobenzoyl)-7-fluoro-4-hydroxy-1,1-dioxido-2H-benzo[e][1,2]thiazin-2-yl)-N-(4-(trifluoromethyl)phenyl)acetamide
Potential treatment - theoretical effect Experimental Antiviral Nov/04/2020
2-(Morpholin-4-yl)-2-oxoethyl 6-(4-methoxyphenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylate
Potential treatment - theoretical effect Experimental Antiviral Dec/17/2020
2-amino-5-chloropyridine hydrogen succinate
Potential treatment - theoretical effect Experimental Antiviral Aug/01/2020
2-Bromo-3-fluoro-N-[(1-methyl-1H-indol-3-yl)sulfonyl]benzamide
Potential treatment - theoretical effect Experimental Antiviral Feb/20/2021
2-Chloro-N-(4-methylsulfonylphenyl)sulfonyl-5-pyrazol-1-ylbenzamide
Potential treatment - theoretical effect Experimental Antiviral Sep/21/2020
2-Ethyl-7,10,11-trimethoxy-3,4-dihydro-1H-phenanthro[9,10-c]pyridin-4-ol
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/14/2020
2-Hydroxy-4-(2-(tosyloxy)acetamido)benzoic acid
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/28/2021
2-picolinic acid
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/16/2020
2-vinyl-4H-1,3-dithiine
Potential treatment - theoretical effect Natural product Antiviral Mar/31/2020
2-[(1R)-1-Naphth-1-ylethyl]-2,3-dihydro-1H-isoindol hydrochloride
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/15/2020
2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]-N-(4-fluorophenyl)acetamide
Potential treatment - theoretical effect Experimental Antiviral Aug/12/2020
2-[[(2R,5R)-5-[(6R)-6-Hydroxy-5-oxo-3,3a,6,6a-tetrahydro-2H-furo[3,2-b]furan-2-yl]oxan-2-yl]-methoxyamino]-N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
Potential treatment - theoretical effect Experimental Antiviral Mar/05/2021